Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents

摘要

The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.